A new animal model for evaluation of long-term growth rate over one month month by rhGH/PLGA microcapsule formulations

Journal of Pharmacy and Pharmacology

Volumn 55, Issue 7, 2003, Pages 951-961

  Takada, Shigeyuki ^a   Kurokawa, Tomofumi ^a   Misaki, Masafumi ^a   Taira, Keiko ^a   Yamagata, Yutaka ^a  

^a TAKEDA PHARMACEUTICAL COMPANY LIMITED   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

HORMONE; HUMAN GROWTH HORMONE; HYDROCORTISONE SODIUM SUCCINATE; IMMUNOSUPPRESSIVE AGENT; LEVOTHYROXINE; POLYGLACTIN; SOMATOMEDIN C; TACROLIMUS;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BODY SIZE; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFECT; DRUG SOLUTION; EMULSION; EVAPORATION; FEMALE; GROWTH HORMONE DEFICIENCY; GROWTH RATE; HYPOPHYSECTOMY; IMMUNOSUPPRESSIVE TREATMENT; INJECTION; LONG TERM CARE; MALE; MICROCAPSULE; NONHUMAN; PHARMACOLOGICAL PARAMETERS; PROTEIN BLOOD LEVEL; RAT; SUPPLEMENTATION; SUSTAINED RELEASE FORMULATION; TREATMENT OUTCOME; WEIGHT GAIN;

ANIMALS; BODY WEIGHT; CAPSULES; CELL DIVISION; CELL LINE; DELAYED-ACTION PREPARATIONS; FEMALE; GROWTH; HUMAN GROWTH HORMONE; HYPOPHYSECTOMY; IMMUNOSUPPRESSION; INJECTIONS, SUBCUTANEOUS; INSULIN-LIKE GROWTH FACTOR I; LACTIC ACID; MALE; MODELS, ANIMAL; POLYGLYCOLIC ACID; POLYMERS; RATS; RATS, SPRAGUE-DAWLEY; SOLUBILITY;

EID: 0042666906     PISSN: 00223573     EISSN: None     Source Type: Journal    
DOI: 10.1211/0022357021323     Document Type: Article

References (34)

1. Bam, N. B., Cleland, J. L., Yang, J., Manning, M. C., Carpenter, J. F., Kelley, R. F., Randolph, T. W. (1998) Tween protects recombinant human growth hormone against agitation-induced damage via hydrophobic interactions. J. Pharm. Sci. 87: 1554-1559
2. Carrasquillo, K. G., Carro, J. C. A., Alejandro, A., Toro, D. D., Griebenow, K. (2001) Reduction of structural perturbations in bovine serum albumin by non-aqueous microencapsulation. J. Pharm. Pharmacol. 53: 115-120
3. Castellanos, I. J., Cuadrado, W. L., Griebenow, K. (2001) Prevention of structural perturbations and aggregation upon microencapsulation of bovine serum albumin into poly(lactide-co-glycolide) microspheres using the solid-in-oil-in-water technique. J. Pharm. Pharmacol. 53: 1099-1107
4. Cavallo, L., DeLuca, F., Bernasconi, S., Russo, R., Zecchino, C., Arrigo, T. (1994) Subcutaneous growth hormone administration in growth-hormone-deficient children. Horm. Res. 42: 86-89
5. Cleland, J. L., Jones, A. J. S. (1996) Stable formulation of recombinant human growth hormone and interferon-γ for microencapsulation in biodegradable polymers. Pharm. Res. 13: 1464-1475
6. Cleland, J. L., Duenas, E., Daugherty, A., Marian, M., Yang, J., Wilson, M., Shahzamani, A., Chu, H., Mukku, V., Maa, Y.-F., Hsu, C., Jones, A. J. S. (1995) Characterization of recombinant human growth hormone - PLGA formulation in animals. Proceed. Int. Symp. Controlled Release Bioact. Mater. 22: 143-144
7. Constantino, H. R., Carrasquillo, K. G., Cordero, R. A., Mumenthaler, M., Hsu, C. C., Griebenow, K. (1998) Effects of excipients on the stability and structure of lyophilized recombinant human growth hormone. J. Pharm. Sci. 87: 1412-1420
8. Evans, H. M., Simpson, M. E., Marx, W., Kibrick, E. (1943) Bioassay of the pituitary growth hormone. Width of the proximal epiphysial cartilage of the tibia in hypophysectomized rats. Endocrinology 32: 13-16
9. Herbert, P., Murphy, K., Johnson, O., Dong, N., Jaworowics, W., Tracy, M., Cleland, J. L., Putney, S. D. (1998) A large-scale process to produce microencapsulated proteins. Pharm. Res. 15: 357-361
10. Johnson, O. L., Cleland, J. L., Lee, H. J., Charnis, M., Duenas, E., Jaworowicz, W., Shepard, D., Shahzamani, A., Jones, A. J. S., Putney, S. D. (1996) A month-long effect from a single injection of microencapsulated human growth hormone. Nat. Med. 2: 795-799
11. Jones, A. J. S., Cleland, J. L. (1996) Technical and regulatory hurdles in delivery aspects of macromolecular drugs. J. Control. Release 41: 147-155
12. Jorgensen, J. O., Moller, N., Lauritzen, T., Christiansen, J. S. (1990) Pulsatile vs. continuous intravenous administration of growth hormone (GH) in GH-deficient patients: Effects on circulating insulin-like growth factor-I and metabolic indices. J. Clin. Endocrinol. Metab. 70: 1616-1623
13. Kim H. K., Park, T. G. (1999) Microencapsulation of human growth hormone within biodegradable polyester microspheres: Protein aggregation stability and incomplete release mechanism. Biotechnol. Bioeng. 65: 659-667
14. Laursen, T., Jorgensen, J. O., Christiansen, J. S. (1994) Metabolic response to growth hormone (GH) administered in a pulsatile, continuous or combined pattern. Endocrinol. Metab. 1: 33-40
15. Laursen, T., Jorgensen, J. O., Jacobsen, G., Hansen, B. L., Christiansen, J. S. (1995) Continuous infusion versus daily injections of growth hormone (GH) for 4 weeks in GH-deficient patients. J. Clin. Endocrinol. Metab. 80: 2410-2418
16. Lee, H. J., Riley, G., Johnson, O. L., Cleland, J. L., Kim, N., Charnis, M., Bailey, L., Duenas, E., Shahzamani, A., Marian, M., Jones, A. J. S., Putney, S. D. (1997) In vivo characterization of sustained-release formulation of human growth hormone. J. Pharmacol. Exp. Ther. 281: 1431-1439
17. Loon, K. V. (1998) Safety of high doses of recombinant human growth hormone. Horm. Res. 49 (Suppl. 2): 78-81
18. Lu, W., Park, T. G. (1995) Protein release from poly(lactic-coglycolic acid) microspheres: Protein stability problems. PDA J. Pharm. Sci. Technol. 49: 13-19
19. Maiter, D., Underwood, L. E., Maes, M., Davenport, M. L., Ketekslegers, J. M. (1988) Different effects of intermittent and continuous growth hormone (GH) administration on serum somatomedin-C/insulin-like growth factor I and liver GH receptors in hypophysectomized rats. Endocrinology 123: 1053-1059
20. Meling, T. R., Nylen, E. S. (1996) Growth hormone deficiency in adults: A review. Am. J. Med. Sci. 311: 153-166
21. Morita, T. Sakamura, Y., Horikiri, Y., Suzuki, T., Yoshino, H. (2000) Protein encapsulation into biodegradable microspheres by a novel S/O/W emulsion method using poly (ethylene glycol) as a protein micronization adjuvant. J. Control. Release 69: 435-444
22. Nishimura, O., Suenaga, M., Ohmae, H., Tsuji, S., Fujino, M. (1998) An efficient chemical method for removing extra methionine from recombinant methionylated human growth hormone. Chem. Commun. 1135-1136
23. Okada H., Heya T., Ogawa Y., Shimamoto T. (1988) One-month release injectable microspheres of a luteinizing hormone-releasing hormone agonist (leuprolide acetate) for treating experimental endometriosis in rats. J. Pharmacol. Exp. Ther. 244: 744-750
24. Ogawa Y., Yamamoto M., Takada S., Okada H., Shimamoto T. (1988) Controlled-release of leuprolide acetate from polylactic acid or copoly(lactic/glycolic) acid microcapsules: Influence of molecular weight and copolymer ratio of polymer. Chem. Pharm. Bull. 36: 1502-1507
25. Park, T. G., Lu, W., Crotts, G. (1995) Importance of in vitro experimental conditions on protein release kinetics, stability and polymer degradation in protein capsulated poly(D,L-lactic acid-co-glycolic acid) microspheres. J. Control. Release 33: 211-222
26. Sah, H. (1999) Stabilization of proteins against methylene chloride/water interface induced denaturation and aggregation. J. Control. Release 58: 143-151
27. Suenaga, M., Ohmae, H., Okutani, N., Kurokawa, T., Asano, T., Yamada, T., Nishimura, O,, Fujino, M. (1999) Further studies on the chemical cleavage of an N-terminal extra methionine from recombinant methionylated proteins. J. Chem. Soc. Perkin Trans. 1: 3727-3733
28. Takada, S., Yamagata, Y., Misaki, M., Taira, K., Kurokawa, T. (2003) Sustained release of human growth hormone from microcapsules prepared by a solvent evaporation technique. J. Control. Release 88: 229-242
29. Tanaka, T., Shiu, R. P. C., Gout, P. W., Beer, C. T., Noble, R. T., Friesen, H. G. (1980) A new sensitive and specific bioassay for lactogenic hormones: Measurement of prolactin and growth hormone in human serum. J. Clin. Endocrinol. Metab. 51: 1058-1063
30. Tauber, M., Portal, H. D. B. D., Sallerin-Caute, B., Rochiccioli, P., Bastide, R. (1993) Differential regulation of serum growth hormone (GH)-binding protein during continuous infusion vs. daily injection of recombinant human GH in GH-deficient children. J. Clin. Endocrinol. Metab. 76: 1135-1139
31. Tracy, M. (1998) Development and scale-up of a microsphere protein delivery system. Biotechnol. Prog. 14: 108-115
32. Van Dyke, H. B., Wallen-Lawrence, Z. (1930) On the growth-promoting hormone of the pituitary body. J. Pharmacol. Exp. Ther. 40: 413-422
33. Yamagata, Y., Misaki, M., Kurokawa, T., Taira, K., Takada, S. (2003) Preparation of a copoly (dl-lactic/glycolic acid)-zinc oxide complex and its utilization to microcapsules containing and its utilization to microcapsules containing recombinant human growth hormone. Int. J. Pharm. 251: 133-141
34. Yang, T.-H., Dong, A., Meyer, J., Johnson, O. L., Cleland, J. L., Carpenter, J. F. (1999) Use of infrared spectroscopy to assess secondary structure of human growth hormone in biodegradable microspheres. J. Pharm. Sci. 88: 161-165